| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 1905887 | Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease | 2006 | 13 Pages | 
Abstract
												Fourteen years after the discovery that mutations in Cu, Zn superoxide dismutase (SOD1) cause a subset of familial amyotrophic lateral sclerosis (fALS), the mechanism by which mutant SOD1 exerts toxicity remains unknown. The two principle hypotheses are (a) oxidative damage stemming from aberrant SOD1 redox chemistry, and (b) misfolding of the mutant protein. Here we review the structure and function of wild-type SOD1, as well as the changes to the structure and function in mutant SOD1. The relative merits of the two hypotheses are compared and a common unifying principle is outlined. Lastly, the potential for therapies targeting SOD1 misfolding is discussed.
Keywords
												
											Related Topics
												
													Life Sciences
													Biochemistry, Genetics and Molecular Biology
													Ageing
												
											Authors
												Rishi Rakhit, Avijit Chakrabartty, 
											